ePSMI for Pancreatic Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how a new web-based program, called ePSMI (electronic Psychological Stress Management Intervention), can help reduce stress for people with pancreatic cancer. The goal is to determine if this program can ease the emotional challenges of cancer. English or Spanish speakers who can read in one of these languages and have been diagnosed with pancreatic cancer might be a good fit for this trial. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance emotional support for cancer patients.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial organizers or your doctor.
What prior data suggests that this program is safe for patients with pancreatic cancer?
Research has shown that ePSMI is an online program designed to help people with pancreatic cancer manage stress. As a digital tool, not a medication or medical device, specific safety data is not available. However, digital programs like this are generally considered low-risk, as they offer support through online resources and typically do not cause physical side effects. For any concerns about joining the trial, discussing them with the trial team can provide more personalized information.12345
Why are researchers excited about this trial?
Unlike the standard chemotherapy and targeted therapies for pancreatic cancer, ePSMI is unique because it offers a novel approach to treatment. Researchers are excited about ePSMI because it potentially targets pancreatic cancer cells more precisely, reducing harm to healthy tissues. This new method might lead to fewer side effects and improved quality of life for patients, making it a promising option in an area with limited effective treatments.
What evidence suggests that ePSMI is effective for reducing psychosocial stress in pancreatic cancer patients?
Research has shown that reducing stress can improve the quality of life for people with pancreatic cancer. Although data on ePSMI, the online program tested in this trial, remains limited, similar programs have successfully helped people manage stress. These programs typically provide tools and resources to aid patients in coping more effectively. Lower stress can lead to overall well-being and may even enhance the effectiveness of other cancer treatments. While evidence for ePSMI is still being gathered in this trial, its approach is based on proven methods to support patients' mental and emotional well-being.12367
Who Is on the Research Team?
Frank Penedo, PhD
Principal Investigator
University of Miami
Are You a Good Fit for This Trial?
This trial is for adults over 18 who have been diagnosed with pancreatic cancer, including those with a specific type called PNET. Participants must be able to read Spanish or English. It's not suitable for individuals with severe psychiatric conditions or any issue that might interfere with their participation as judged by the study leader.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the ePSMI intervention, a web-based program aimed at reducing psychosocial stress, for up to ten weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Long-term follow-up
Participants are monitored for recruitment, participation, and retention rates, as well as disease progression and other long-term outcomes
What Are the Treatments Tested in This Trial?
Interventions
- ePSMI
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Miami
Lead Sponsor
U.S. Army Medical Research and Development Command
Collaborator